Boundless Bio Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Boundless Bio Inc had 17.48M in cash and cash equivalents.

Boundless Bio Inc reported 58.41M in total liabilities as of the latest reported quarter, including 12.54M in current liabilities and 45.87M in non-current liabilities.

As of the latest reported quarter, Boundless Bio Inc's total assets were 157.06M, consisting of 109.61M in current assets and 47.45M in non-current assets.

Boundless Bio Inc reported 98.65M in total shareholders' equity as of the latest reported quarter.